Pharma Tablet Presses
Manual to automatic rotary tablet press for research, pilot-scale and full production, presses for normal, clean-room, contained and highly contained environments and presses for the production of single and bi-layer tablets.
GEA's strong drive to innovate and improve the compaction process is reflected in the unique design and patented features present throughout our rotary tablet press range.
Our R&D and engineering departments constantly focus on increasing the productivity and flexibility of our tablet presses, improving tablet quality and enhancing operator safety.
Discover NexGen Press®
We have combined the very best aspects of the MODUL and PERFORMA tablet compression lines into a new range: NexGen Press®.
Every aspect of each machine has been deconstructed, analyzed, upgraded and reassembled to represent the best-in-class solution for the widest range of tableting applications, with the aim of enhancing productivity, flexibility and sustainability.
Products
Showing 4 of 4
NexGen Press® 30
Combining the best features of the MODUL-P and PERFORMA-P, the NexGen Press® 30 is ideally suited for formulation development, clinical trial production and small batch/multi-product production. It is modular by design and can be configured to fit specific applications, such as bi-layer compression, MUPS, micro-tablets, OEB levels from 1 to 5, wi...
NexGen Press® 45
The NexGen Press® 45 represents the ultimate combination of modular design, digitization, safety, ease of use and ergonomic functionality, while providing high throughputs for larger tablet production campaigns.
NexGen Press® range
Featuring an innovative design that promotes operator (and environmental) safety and ease of use, the NexGen Press® range is modular, intuitive and cost-effective to run, combining unrivaled containment with fast product changeovers and the best price-performance tableting system..
PERFORMA D Tablet Press
The commercial-scale PERFORMA D is the latest addition to GEA’s portfolio of rotary tablet presses. Designed for the reliable and cost-effective large-scale production of oral solid dosage forms, the new double-sided model combines the benefits of flexibility and robust performance for a wide range of formulations.
Downloads
GEA Insights
Turning wastewater into value
GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.
Around the world in seven questions: New foods we’ll love
Last year was not a year of hyped-up headlines for alternative proteins. Perhaps that is precisely why it was an important year for food biotech, the biotechnology behind everyday foods and ingredients. While the sector worked through a difficult funding environment, approvals were still granted, pilot lines set up and new platforms tested in the background. In short: headlines are turning into infrastructure. Frederieke Reiners heads GEA’s New Food business. She and her team work at the intersection of biotechnology and industrial food production. In this interview, she takes us on a world tour of food biotech in seven questions.
How freeze-dried pet food raises the bar
Pets are family – and owners expect premium, transparent and sustainable nutrition. Freeze-drying, powered by GEA technology, helps pet food makers deliver.
